Related keylists
Aier Eye Hospital Group Co Ltd (Aier Eye Hospital) operates a network of hospitals for eye care. The company provides surgical services and medical optometry. It offers clinical medicine, medical education, and academic research programs. The company mainly provides corneal refractive surgery, cataract operation, anterior segment operation, posterior segment operation and optometry services. It also provides international training for cataract prevention and treatment, the training base for subspecialty surgeons and resident physicians. The company mainly operates its business in the domestic market, with Central China as its main market. Aier Eye Hospital is headquartered in Changsha, Hunan, China.
Headquarters
China
Address
Na02, Changsha, Hunan, 410000
Website
www.aierchina.com
Telephone
86 731 85136739
No of Employees
32,326
Industry
Pharmaceuticals and Healthcare
Ticker Symbol & Exchange
300015 (SHE)
Revenue (2022)
$2.4B
7.4%
(2022 vs 2021)
EPS
XYZ
Net Income (2022)
XYZ
8.6%
(2022 vs 2021)
Market Cap*
$16.1B
Net Profit Margin (2022)
XYZ
1.2%
(2022 vs 2021)
* As of and is in US$
Aier Eye Hospital Group Co Ltd premium industry data and analytics
Products and Services
| Services |
|---|
| Eye Care Services |
| Training |
| Academic Research |
| XYZ |
| XYZ |
| XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2023 | Plans/Strategy | In January, the company announced its plans to acquire 70% stake in Zhoushan Aier Guangming Eye Hospital from Tianjin Aisin Enterprise Management. |
| 2023 | Plans/Strategy | In January, the company announced its plans to acquire 51% stake in Baoji Aier Eye Hospital from Tianjin Aisin Enterprise Management. |
| 2023 | Plans/Strategy | In January, the company announced its plans to acquire 70% stake in Ezhou Aier Eye Hospital from Tianjin Aisin Enterprise Management. |
Competitor Comparison
| Key Parameters | Aier Eye Hospital Group Co Ltd | Shanghai Fosun Pharmaceutical (Group) Co Ltd | Zhejiang Conba Pharmaceutical Co Ltd | Kangmei Pharmaceutical Co Ltd | Jianmin Pharmaceutical Group Co Ltd |
|---|---|---|---|---|---|
| Headquarters | China | China | China | China | China |
| City | Changsha | Shanghai | Hangzhou | Shenzhen | Wuhan |
| State/Province | Hunan | Shanghai | Zhejiang | Guangdong | Hubei |
| No. of Employees | 32,326 | 38,399 | 8,415 | 6,371 | 2,248 |
| Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Chen Bang | Chairman | Executive Board | 2007 | 58 |
| Li Li | General Manager; Vice Chairman | Executive Board | 2007 | 58 |
| Wu Shijun | Director; Deputy General Manager; Secretary | Executive Board | 2018 | 51 |
| Han Zhong | Director; Deputy General Manager | Executive Board | 2012 | 58 |
| Liu Duoyuan | Chief Financial Officer; Deputy General Manager | Senior Management | 2018 | 61 |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward